ライフサイエンスコーパス: serodiagnostic

1 potential virulence factors and as candidate serodiagnostic and immunoprotective reagents.

2 in microarray data analysis is identifying a serodiagnostic antigen set that can reliably detect patt

3 therefore a significantly improved source of serodiagnostic antigens compared to the traditional sour

4 the rP43 and rP28 are sensitive and reliable serodiagnostic antigens for E. canis infections.

5 reviously shown to be sensitive and specific serodiagnostic antigens for HME and HGE, respectively, c

6 responses against some of the same potential serodiagnostic antigens reported previously, as well as

7 Five potential serodiagnostic antigens were evaluated on immunostrips,

8 About 72% of the serodiagnostic antigens were within the top 25% of the r

9 and population-specific basis, can identify serodiagnostic antigens, and contribute to a more detail

10 suitability of the these 90-kDa proteins as serodiagnostic antigens.

11 d the responses against additional potential serodiagnostic antigens.

12 B1 lipoproteins could be the basis for a new serodiagnostic assay for Lyme disease.

13 Taenia solium, has been the "gold standard" serodiagnostic assay since it was first described in 198

14 y antigens that might complement r38kDa in a serodiagnostic assay.

15 igens with reduced cross-reactivity in these serodiagnostic assays and others should lead to more acc

16 ngi has hampered the development of specific serodiagnostic assays for histoplasmosis.

17 degree of cross-reactivity observed in most serodiagnostic assays.

18 otein correlated with elevated titers to the serodiagnostic complement fixation antigen of C. immitis

19 surveillance questionnaires and standardized serodiagnostic criteria.

20 es, and this may require revision of current serodiagnostic criteria.

21 To determine the serodiagnostic discriminatory ability of the antigens wi

22 ntical to that of the native protein and had serodiagnostic efficacy comparable to those of the comme

23 HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 a

24 ential candidate proteins for developing new serodiagnostics for African trypanosomiasis.

25 Current serodiagnostics for Lyme disease lack sensitivity during

26 the recombinant protein may be useful in the serodiagnostic identification of A. fumigatus infections

27 not the 19- and 60-kDa antigens observed on serodiagnostic immunoblots.

28 ex of Epstein-Barr virus (EBV), an important serodiagnostic marker of infection with the virus, consi

29 mydia CFT, which is the most widely accepted serodiagnostic method for chlamydial infections in anima

30 5C, MPT32, and a 88-kDa protein) have strong serodiagnostic potential.

31 and preclinical tuberculosis and to identify serodiagnostic proteins for the spectrum of bacillary bu

32 When tested by the Iatron serodiagnostic reagent kit (Iatron Laboratories, Inc.),

33 they are logical candidates for vaccine and serodiagnostic reagents.

34 ere is an urgent need for development of new serodiagnostic strategies for leptospirosis, an emerging

35 ntify epitopes of alpha-actinin as candidate serodiagnostic targets and suggest strongly that a highl

36 ression as well as define key protective and serodiagnostic targets.

37 n of borreliacidal antibodies is an accurate serodiagnostic test for confirmation of Lyme disease in

38 for the inclusion of rCFP-10 in a polyvalent serodiagnostic test for detection of active TB infection

39 urgdorferi isolate 50772, is also a reliable serodiagnostic test for detection of Lyme disease in dog

40 can be used to devise a simple peptide-based serodiagnostic test for TB.

41 There is a need for a point-of-care serodiagnostic test for women and men for sexually trans

42 nclusion of recombinant MTB48 in a prototype serodiagnostic test increases assay sensitivity for M. t

43 argeted PCR assay and an radaA antigen-based serodiagnostic test may be useful for differential diagn

44 Development of an accurate serodiagnostic test requires a detailed understanding of

45 This serodiagnostic test was validated through a hyperimmuniz

46 Importantly, this novel serodiagnostic test would be useful independent of prior

47 Comparison of the P37 EIA with the current serodiagnostic test, a bacterial lysate EIA, revealed re

48 utination assay (IHA) is used as a reference serodiagnostic test; however, it has low specificity in

49 al patient sera presented here suggests that serodiagnostic tests based on the subset of antigens rec

50 y presents a challenge to the development of serodiagnostic tests for other intracellular pathogens t

51 encephalitis virus (JEV) are widely used as serodiagnostic tests for presumptive confirmation of vir

52 compared the performance of European and US serodiagnostic tests, including newer-generation assays

53 nt an urgent need for sensitive and specific serodiagnostic tests, particularly for pregnant women in

54 uld aid the design of Lig-based vaccines and serodiagnostic tests.

55 or positive reactivities with more specific serodiagnostic tests.

56 -kDa antigen, an immunodominant antigen with serodiagnostic value, which has been previously cloned a